Victory Capital Management’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.52M Sell
174,787
-37,107
-18% -$1.17M ﹤0.01% 1283
2025
Q1
$7.03M Buy
211,894
+65,285
+45% +$2.17M 0.01% 1179
2024
Q4
$5.04M Buy
146,609
+77,611
+112% +$2.67M 0.01% 1262
2024
Q3
$2.76M Sell
68,998
-15,966
-19% -$639K ﹤0.01% 1400
2024
Q2
$2.56M Buy
84,964
+29,816
+54% +$900K ﹤0.01% 1369
2024
Q1
$1.85M Buy
55,148
+37,368
+210% +$1.25M ﹤0.01% 1476
2023
Q4
$574K Sell
17,780
-14,809
-45% -$478K ﹤0.01% 1959
2023
Q3
$1.07M Buy
32,589
+3,605
+12% +$118K ﹤0.01% 1622
2023
Q2
$1.02M Sell
28,984
-14,579
-33% -$513K ﹤0.01% 1664
2023
Q1
$1.42M Buy
43,563
+3,317
+8% +$108K ﹤0.01% 1522
2022
Q4
$2.22M Buy
40,246
+18,592
+86% +$1.02M ﹤0.01% 1398
2022
Q3
$959K Sell
21,654
-139
-0.6% -$6.16K ﹤0.01% 1755
2022
Q2
$1.06M Sell
21,793
-3,302
-13% -$161K ﹤0.01% 1711
2022
Q1
$1.13M Buy
25,095
+14,877
+146% +$670K ﹤0.01% 1741
2021
Q4
$436K Buy
+10,218
New +$436K ﹤0.01% 2220